Bioavailability Study of K0706 in Healthy Subjects
Status:
Completed
Trial end date:
2017-11-21
Target enrollment:
Participant gender:
Summary
This is single-center, single-dose, randomized, open-label, four-period, four sequence
crossover study to evaluate the relative bioavailability of K0706 24 mg tablet formulation
relative to 24 mg capsule formulation under fasted conditions and to evaluate the food-effect
for tablet formulation in healthy subjects.